GHAM
DXCM icon

Gilman Hill Asset Management’s DexCom DXCM Stock Holding History

Gilman Hill Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,608
Closed -$216K – 209
2021
Q4 		$216K Buy
+1,608
New +$231K 0.05% 205

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Gilman Hill Asset Management's DXCM Position: Q1 2022 in Review

Gilman Hill Asset Management sold out of DexCom (DXCM) in Q1 2022, closing a stake of 1,608 shares — an estimated $216K sold.

Gilman Hill Asset Management first reported a position in DXCM in Q4 2021 and held it in 1 quarter. The position peaked at $216K in Q4 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • Gilman Hill Asset Management reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • Gilman Hill Asset Management sold 1,608 DexCom shares in Q1 2022, an estimated $216K.
  • Gilman Hill Asset Management first reported a position in DexCom in Q4 2021 and held it in 1 quarter.
  • Gilman Hill Asset Management's DexCom position peaked at $216K in Q4 2021.
  • 861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Gilman Hill Asset Management's 13F filing for Q1 2022, filed 14 Apr 2022.